Lilly signs $1.3 billion deal with Superluminal to discover obesity medicines using AI Reuters Nawigacja wpisu Transforming Parkinson’s disease treatment, Insilico Medicine announces IND-enabling completion for AI-empowered oral NLRP3 inhibitor ISM8969 – EurekAlert! Tensions rise as Penn Medicine calls police on union supporters at Lancaster Behavioral Health Hospital – fox43.com
